2021年7-8月联邦监狱中感染SARS-CoV-2 Delta变异株的已接种和未接种者的传播潜力
在疫苗接种率高的联邦监狱Delta变异株暴发中,93名感染者(78人接种,17人未接种)连续10天提供鼻拭子。接种与未接种者的RT-PCR阳性持续时间(中位13天 vs 13天,p=0.50)和病毒培养阳性持续时间(中位5天 vs 5天,p=0.29)无显著差异。接种者中Moderna受种者培养阳性持续时间短于Pfizer(p=0.048)或Janssen(p=0.003)受种者。
要点
- 接种与未接种感染者RT-PCR阳性持续时间无显著差异(中位13天 vs 13天,p=0.50)。
- 接种与未接种感染者病毒培养阳性持续时间无显著差异(中位5天 vs 5天,p=0.29)。
- 接种者中Moderna受种者培养阳性持续时间短于Pfizer(p=0.048)或Janssen(p=0.003)受种者。
核心结论
- 已接种和未接种者感染SARS-CoV-2后的传染期相似且可能高度可变,尽管部分接种者可能传染期较短。
- 在病毒传播可导致大规模暴发的聚集性场所,临床医生和公共卫生从业者应考虑已接种感染者的传染性不低于未接种感染者。
研究设计与样本
- 在疫苗接种率高的联邦监狱SARS-CoV-2 Delta变异株暴发期间,对同意参与的实验室确诊SARS-CoV-2感染囚犯连续10天每日提供中鼻甲鼻拭子并通过问卷报告症状数据。
- 对鼻拭子进行实时逆转录聚合酶链反应(RT-PCR)、病毒全基因组测序和病毒培养。
- 采用生存分析评估RT-PCR阳性和病毒培养阳性的持续时间。
主要发现
- 93名参与者共提供957份标本,其中78人(84%)已接种,17人(16%)未接种。
- 已接种者RT-PCR阳性持续时间(中位13天)与未接种者(中位13天)无显著差异(p=0.50)。
- 已接种者病毒培养阳性持续时间(中位5天)与未接种者(中位5天)无显著差异(p=0.29)。
- 已接种者中,Moderna受种者总体病毒培养阳性持续时间短于Pfizer受种者(p=0.048)或Janssen受种者(p=0.003)。
- 事后分析中,Moderna受种者病毒培养阳性持续时间显著短于未接种者(p=0.02);限制于无既往感染报告者时差异更明显(中位3天 vs 6天,p=0.002)。
临床怎么用
- 在聚集性场所,临床医生和公共卫生从业者应考虑已接种的感染者传染性不低于未接种的感染者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The extent to which vaccinated persons who become infected with SARS-CoV-2 contribute to transmission is unclear. During a SARS-CoV-2 Delta variant outbreak among incarcerated persons with high vaccination rates in a federal prison, we assessed markers of viral shedding in vaccinated and unvaccinated persons. METHODS: Consenting incarcerated persons with confirmed SARS-CoV-2 infection provided mid-turbinate nasal specimens daily for 10 consecutive days and reported symptom data via questionnaire. Real-time reverse transcription-polymerase chain reaction (RT-PCR), viral whole genome sequencing, and viral culture was performed on these nasal specimens. Duration of RT-PCR positivity and viral culture positivity was assessed using survival analysis. RESULTS: A total of 957 specimens were provided by 93 participants, of whom 78 (84 %) were vaccinated and 17 (16 %) were unvaccinated. No significant differences were detected in duration of RT-PCR positivity among vaccinated participants (median: 13 days) versus those unvaccinated (median: 13 days; p = 0.50), or in duration of culture positivity (medians: 5 days and 5 days; p = 0.29). Among vaccinated participants, overall duration of culture positivity was shorter among Moderna vaccine recipients versus Pfizer (p = 0.048) or Janssen (p = 0.003) vaccine recipients. In post-hoc analyses, Moderna vaccine recipients demonstrated significantly shorter duration of culture positivity compared to unvaccinated participants (p = 0.02). When restricted to participants without reported prior infection, the difference between Moderna vaccine recipients and unvaccinated participants was more pronounced (medians: 3 days and 6 days, p = 0.002). CONCLUSIONS: Infectious periods for vaccinated and unvaccinated persons who become infected with SARS-CoV-2 are similar and can be highly variable, though some vaccinated persons are likely infectious for shorter durations. These findings are critically important, especially in congregate settings where viral transmission can lead to large outbreaks. In such settings, clinicians and public health practitioners should consider vaccinated, infected persons to be no less infectious than unvaccinated, infected persons.
引用
- Salvatore PP, Lee CC, Sleweon S, et al. Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021. Vaccine. 2022. PMID: 36572604. doi:10.1016/j.vaccine.2022.11.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。